Eudocia Lee

Trials

Studies that name Eudocia Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:50 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT03107780 · Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer

  National Cancer Institute (NCI) · terminated · Glioblastoma, Gliosarcoma, MGMT-Unmethylated Glioblastoma · principal investigator
• Ph2
  NCT02478164 · Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma

  Dana-Farber Cancer Institute · completed · Glioblastoma · principal investigator
• Ph2
  NCT00766467 · A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

  Eudocia Quant Lee, MD · completed · Malignant Glioma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Alliance for Clinical Trials in Oncology Member Site Core
  U10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026
  Named on NCT03107780
• Adult Brain Tumor Consortium (ABTC)
  UM1CA137443 · NCI · JOHNS HOPKINS UNIVERSITY · PI STUART A GROSSMAN · fiscal years 2014 to 2020
  Named on NCT03107780